FI972660A0 - Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina - Google Patents

Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina

Info

Publication number
FI972660A0
FI972660A0 FI972660A FI972660A FI972660A0 FI 972660 A0 FI972660 A0 FI 972660A0 FI 972660 A FI972660 A FI 972660A FI 972660 A FI972660 A FI 972660A FI 972660 A0 FI972660 A0 FI 972660A0
Authority
FI
Finland
Prior art keywords
piperazine
multidrug resistance
dione derivatives
resistance modulators
modulators
Prior art date
Application number
FI972660A
Other languages
English (en)
Swedish (sv)
Other versions
FI972660A (fi
Inventor
Philip Anthony Ashworth
Sukhjit Hunjan
Ian Andrew Pretswell
Hamish Ryder
Stephen James Brocchini
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Publication of FI972660A0 publication Critical patent/FI972660A0/fi
Publication of FI972660A publication Critical patent/FI972660A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI972660A 1994-12-23 1997-06-19 Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina FI972660A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9426224.3A GB9426224D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
PCT/GB1995/003027 WO1996020190A1 (en) 1994-12-23 1995-12-22 Piperazine 2,5 dione derivatives as modulators of multi-drug resistance

Publications (2)

Publication Number Publication Date
FI972660A0 true FI972660A0 (fi) 1997-06-19
FI972660A FI972660A (fi) 1997-08-22

Family

ID=10766589

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972660A FI972660A (fi) 1994-12-23 1997-06-19 Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina

Country Status (19)

Country Link
EP (1) EP0799222A1 (fi)
JP (1) JPH10511384A (fi)
CN (1) CN1175253A (fi)
AU (1) AU698828B2 (fi)
BG (1) BG101602A (fi)
BR (1) BR9510410A (fi)
CA (1) CA2207500A1 (fi)
CZ (1) CZ190097A3 (fi)
FI (1) FI972660A (fi)
GB (1) GB9426224D0 (fi)
HU (1) HUT77943A (fi)
IL (1) IL116525A0 (fi)
NO (1) NO972937L (fi)
NZ (1) NZ297847A (fi)
PL (1) PL320916A1 (fi)
SK (1) SK83697A3 (fi)
TW (1) TW358094B (fi)
WO (1) WO1996020190A1 (fi)
ZA (1) ZA9510909B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA979329B (en) * 1996-10-18 1999-04-19 Xenova Ltd Pharmaceutical compounds
GB9717576D0 (en) * 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
CA2346689A1 (en) 1998-10-08 2000-04-20 Gregor James Macdonald Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
IL150430A0 (en) * 2000-01-18 2002-12-01 Nereus Pharmaceuticals Inc Cell division inhibitors and process for producing the same
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US7919497B2 (en) 2002-08-02 2011-04-05 Nereus Pharmaceuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
US7935704B2 (en) 2003-08-01 2011-05-03 Nereus Pharmaceuticals, Inc. Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
IL166628A0 (en) 2002-08-02 2006-01-15 Nereus Pharmaceuticals Inc Dehydrophenyl lahistins and analogs thereof and the synthesis of dehydrophenyllahistins and analogs thereof
US8129527B2 (en) 2006-11-03 2012-03-06 Nereus Pharmacuticals, Inc. Analogs of dehydrophenylahistins and their therapeutic use
CN103396372B (zh) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 一类2,5-二酮哌嗪衍生物及其制备方法和在制备抗海洋污损生物防除剂中的应用
US10076518B2 (en) 2015-03-06 2018-09-18 Beyondspring Pharmaceuticals, Inc. Method of treating a brain tumor
US10238650B2 (en) 2015-03-06 2019-03-26 Beyondspring Pharmaceuticals, Inc. Method of treating cancer associated with a RAS mutation
MX2018000451A (es) 2015-07-13 2018-05-07 Beyondspring Pharmaceuticals Inc Composiciones de plinabulina.
RU2753543C1 (ru) 2016-02-08 2021-08-17 Бейондспринг Фармасьютикалс, Инк. Композиции, содержащие тукаресол или его аналоги
WO2017214052A1 (en) 2016-06-06 2017-12-14 Beyondspring Pharmaceuticals, Inc. Composition and method for reducing neutropenia
WO2018129381A1 (en) 2017-01-06 2018-07-12 Beyondspring Pharmaceuticals, Inc. Tubulin binding compounds and therapeutic use thereof
JP2020514412A (ja) 2017-02-01 2020-05-21 ビヨンドスプリング ファーマシューティカルズ,インコーポレイテッド 好中球減少症の低減方法
KR20200112881A (ko) 2018-01-24 2020-10-05 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0649410B1 (en) * 1992-07-10 1997-05-02 Laboratoires Glaxo Sa Anilide derivatives
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
IL116525A0 (en) 1996-03-31
WO1996020190A1 (en) 1996-07-04
BG101602A (en) 1998-02-27
ZA9510909B (en) 1996-08-30
AU4310096A (en) 1996-07-19
NO972937D0 (no) 1997-06-23
NO972937L (no) 1997-06-23
GB9426224D0 (en) 1995-02-22
TW358094B (en) 1999-05-11
AU698828B2 (en) 1998-11-05
EP0799222A1 (en) 1997-10-08
HUT77943A (hu) 1998-12-28
CA2207500A1 (en) 1996-07-04
JPH10511384A (ja) 1998-11-04
PL320916A1 (en) 1997-11-10
SK83697A3 (en) 1998-05-06
CZ190097A3 (cs) 1998-01-14
BR9510410A (pt) 1999-09-08
NZ297847A (en) 1999-04-29
FI972660A (fi) 1997-08-22
CN1175253A (zh) 1998-03-04

Similar Documents

Publication Publication Date Title
FI972660A0 (fi) Piperatsini-2,5-dionijohdannaiset monilääke resistanssi modulaattoreina
NO991563L (no) N-substituerte, azaheterosykliske forbindelser
IS4963A (is) Setnar 6,5-heteró-bísýklískar afleiður
ATE264327T1 (de) Substituierte 6,6-heterobicyclische derivate
DE69809755D1 (de) Substituierte 1,2,3,4-tetrahydronaphthalin derivate
DE69508180D1 (de) Heissschmelzende Tintenstrahlzusammensetzung
ATE246199T1 (de) 3-descladinose-2,3-anhydroerythromycin-derivate
AU8356098A (en) Novel hexahydro-1,4-diazepine derivatives or salts thereof
NO982124L (no) Kondenserte imidazolderivater som multilegemiddel resistanse modulatorer
DE69628458D1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalceriferol derivate
FR2722181B1 (fr) Plieuse.
NL1013652A1 (nl) Piperazinonderivaten.
NO995491D0 (no) Polyolefin inneholdende polyeteraminmodifisert funksjonalisert polyolefin
AU4310196A (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
NO20015397L (no) 1,5-Benzodiazepin-derivater
FI972885A0 (fi) Anordning foer utfoering av en divisionoperation, saerskilt i en tredimensionell grafik
ES1036800Y (es) Bicicleta plegable.
ITTO940791A0 (it) Composizione adesiva.
ES1033728Y (es) Bolsa plegable perfeccionada.
GB2310854B (en) Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
TR199600665A2 (tr) Asimetrik trifenilendioksazin bilesikleri.
ES1037001Y (es) Carpeta perfeccionada.
ES1037110Y (es) Maquina envasadora perfeccionada.
ES1034154Y (es) Carpeta perfeccionada.
GB9815066D0 (en) Piperazine 2, 5-dione derivatives as modulators of multidrug resistance